# Jasper Therapeutics, Inc.: Form 8-K, filed Nov 10, 2022

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2022-11-10
- Accepted by EDGAR: Nov 10, 2022, 17:03 ET
- Period: 2022-11-10
- Accession: 0001213900-22-071292
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390022071292/ea168358-8k_jaspertherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390022071292/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390022071292/ea168358-8k_jaspertherap.htm

Filed Nov 10, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-071292. Last ingested by Listed: Nov 4, 2026, 08:12 ET. No prices; not investment advice.